Acutus Medical Inc logo

AFIB - Acutus Medical Inc Share Price

$8.9 -0.7  -7.2%

Last Trade - 3:44pm

Small Cap
Market Cap £243.6m
Enterprise Value £217.0m
Revenue £10.3m
Position in Universe 4241st / 7157
Unlock AFIB Revenue
Relative Strength (%)
1m -25.5%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -72.1%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.000 2.17 2.84 8.46 23.0 58.2 +97.7%
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 June 2021, AcutusMedical Inc revenues increased from $2.7M to $8.3M. Netloss increased 40% to $57.9M. Revenues reflect Europesegment increase from $814K to $2M, United States segmentincrease from $769K to $1.6M. Higher net loss reflectsSelling, general and administrative increase of 57% to$26.7M (expense), Stock-based Compensation in SGA increasefrom $2.4M to $5.2M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


AFIB Revenue Unlock AFIB Revenue

Net Income

AFIB Net Income Unlock AFIB Revenue

Normalised EPS

AFIB Normalised EPS Unlock AFIB Revenue

PE Ratio Range

AFIB PE Ratio Range Unlock AFIB Revenue

Dividend Yield Range

AFIB Dividend Yield Range Unlock AFIB Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
AFIB EPS Forecasts Unlock AFIB Revenue
Profile Summary

Acutus Medical, Inc. is an arrhythmia management company. The Company designs, manufactures and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. The Company’s product portfolio includes access sheaths, transseptal crossing tools, diagnostic and mapping catheters, ablation catheters, mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Its AcQMap System consists of the single-use AcQMap catheter as well as its console, workstation and software algorithms. With 48 ultrasound transducers interspersed between 48 biopotential electrodes, its mapping catheter collects the data required to create a map of the cardiac anatomy and electrical propagation pathways and patterns. The Company’s software algorithms analyze the biopotential data and maps any type of arrhythmia, including atrial fibrillation, as well as all supraventricular tachycardias and ventricular arrhythmias.

Last Annual December 31st, 2020
Last Interim June 30th, 2021
Incorporated March 25, 2011
No. of Shareholders: n/a
No. of Employees: 291
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Nasdaq Composite ,
Exchange NASDAQ Global Select Market
Shares in Issue 34,607,593
Free Float (0.0%)
Eligible for
AFIB Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for AFIB
Upcoming Events for AFIB
Wednesday 10th November, 2021 Estimate
Q3 2021 Acutus Medical Inc Earnings Release
Wednesday 16th March, 2022 Estimate
Q4 2021 Acutus Medical Inc Earnings Release
Frequently Asked Questions for Acutus Medical Inc
What is the Acutus Medical Inc share price?

As of 3:44pm, shares in Acutus Medical Inc are trading at $8.9, giving the company a market capitalisation of £243.6m. This share price information is delayed by 15 minutes.

How has the Acutus Medical Inc share price performed this year?

Shares in Acutus Medical Inc are currently trading at $8.9 and the price has moved by -68.27% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Acutus Medical Inc price has moved by -76.41% over the past year.

What are the analyst and broker recommendations for Acutus Medical Inc?

There are no analysts currently covering Acutus Medical Inc.

When will Acutus Medical Inc next release its financial results?

Acutus Medical Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-06-30
What is the Acutus Medical Inc dividend yield?

Acutus Medical Inc does not currently pay a dividend.

Does Acutus Medical Inc pay a dividend?

Acutus Medical Inc does not currently pay a dividend.

When does Acutus Medical Inc next pay dividends?

Acutus Medical Inc does not currently pay a dividend.

How do I buy Acutus Medical Inc shares?

To buy shares in Acutus Medical Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Acutus Medical Inc?

Shares in Acutus Medical Inc are currently trading at $8.9, giving the company a market capitalisation of £243.6m.

Where are Acutus Medical Inc shares listed? Where are Acutus Medical Inc shares listed?

Here are the trading details for Acutus Medical Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: AFIB
What kind of share is Acutus Medical Inc?

Based on an overall assessment of its quality, value and momentum, Acutus Medical Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Acutus Medical Inc share price forecast 2021?

Shares in Acutus Medical Inc are currently priced at $8.9. At that level they are trading at 0.116% discount to the analyst consensus target price of 0.00.

Analysts covering Acutus Medical Inc currently have a consensus Earnings Per Share (EPS) forecast of -3.728 for the next financial year.

How can I tell whether the Acutus Medical Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Acutus Medical Inc. Over the past six months, the relative strength of its shares against the market has been -35.21%. At the current price of $8.9, shares in Acutus Medical Inc are trading at -46.96% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Acutus Medical Inc PE Ratio?

We were not able to find PE ratio data for Acutus Medical Inc.

Who are the key directors of Acutus Medical Inc?

Acutus Medical Inc's management team is headed by:

Tim Corvi - VRD
Steven McQuillan - SVP
Vince Burgess - PRE
R. Scott Huennekens - CHM
David Bonita - IND
Andrew Elbardissi - IND
James Hinrichs - IND
Shaden Marzouk - IND
David Roman - CFO
Daniella Cramp - IND
Who are the major shareholders of Acutus Medical Inc?

Here are the top five shareholders of Acutus Medical Inc based on the size of their shareholding:

Deerfield Management Company, L.P. Hedge Fund
Percentage owned: 7.65% (2.65m shares)
OrbiMed Advisors, LLC Investment Advisor/Hedge Fund
Percentage owned: 7.65% (2.65m shares)
Capital Research Global Investors Investment Advisor
Percentage owned: 6.12% (2.12m shares)
Capital World Investors Investment Advisor
Percentage owned: 6.12% (2.12m shares)
American Funds SMALLCAP World Fund Mutual Fund
Percentage owned: 6.12% (2.12m shares)
Similar to AFIB
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.